Telix Pharmaceuticals now on the buy list at Jarden Brokers
SYDNEY: Shares in cancer biotech Telix Pharmaceuticals are up 51.5 per cent for the year,
SYDNEY: Shares in cancer biotech Telix Pharmaceuticals are up 51.5 per cent for the year,
FEATURED
Special research team creates ‘predictive medicine’ AI tool
Gen Z fear they will be poorest generation
New development earmarked for hospitality and multigenerational living
Public notification opens for 25-unit project on former landfill
Nine-story homeless tower rejected by council in shock vote
Multigenerational affordable housing planned for regeneration site
INNOVATION
